Master Pharm SA

WSE:MPH Lagerbericht

Marktkapitalisierung: zł119.7m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Master Pharm Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 0/6

Wichtige Informationen

-21.5%

Wachstumsrate der Gewinne

-18.8%

EPS-Wachstumsrate

Personal Products Wachstum der Industrie36.3%
Wachstumsrate der Einnahmen3.4%
Eigenkapitalrendite2.0%
Netto-Marge2.1%
Nächste Ertragsaktualisierung17 Nov 2022

Jüngste Aktualisierungen vergangener Leistungen

Recent updates

Calculating The Intrinsic Value Of Master Pharm SA (WSE:MPH)

Feb 05
Calculating The Intrinsic Value Of Master Pharm SA (WSE:MPH)

Returns On Capital At Master Pharm (WSE:MPH) Have Hit The Brakes

Dec 13
Returns On Capital At Master Pharm (WSE:MPH) Have Hit The Brakes

A Look At The Intrinsic Value Of Master Pharm SA (WSE:MPH)

May 25
A Look At The Intrinsic Value Of Master Pharm SA (WSE:MPH)

Master Pharm (WSE:MPH) Will Will Want To Turn Around Its Return Trends

Mar 30
Master Pharm (WSE:MPH) Will Will Want To Turn Around Its Return Trends

Is Master Pharm SA's (WSE:MPH) Latest Stock Performance Being Led By Its Strong Fundamentals?

Mar 02
Is Master Pharm SA's (WSE:MPH) Latest Stock Performance Being Led By Its Strong Fundamentals?

I Ran A Stock Scan For Earnings Growth And Master Pharm (WSE:MPH) Passed With Ease

Feb 04
I Ran A Stock Scan For Earnings Growth And Master Pharm (WSE:MPH) Passed With Ease

Master Pharm (WSE:MPH) Is Growing Earnings But Are They A Good Guide?

Jan 08
Master Pharm (WSE:MPH) Is Growing Earnings But Are They A Good Guide?

Here's What To Make Of Master Pharm's (WSE:MPH) Returns On Capital

Dec 18
Here's What To Make Of Master Pharm's (WSE:MPH) Returns On Capital

Master Pharm SA (WSE:MPH) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Nov 27
Master Pharm SA (WSE:MPH) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Aufschlüsselung der Einnahmen und Ausgaben

Wie Master Pharm Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.

Gewinn- und Umsatzhistorie

WSE:MPH Einnahmen, Ausgaben und Erträge (PLN Millions)
DatumEinnahmenUmsatzAllgemeine und VerwaltungskostenF&E-Ausgaben
30 Jun 22792240
31 Mar 2273410
31 Dec 21774220
30 Sep 2172-3210
30 Jun 21752210
31 Mar 21691200
31 Dec 20610200
30 Sep 206312220
30 Jun 206813220
31 Mar 207112240
31 Dec 197113240
30 Sep 19739260
30 Jun 19749270
31 Mar 19729270
31 Dec 187511270
30 Sep 187511260
30 Jun 187010260
31 Mar 18689240
31 Dec 17648240
30 Sep 17577230
30 Jun 17526210
31 Mar 17518210
31 Dec 16497190
30 Sep 16508190
30 Jun 16537190
31 Mar 16539180
31 Dec 15498160
30 Sep 15438130

Qualität der Erträge: MPH has a large one-off loss of PLN7.4M impacting its June 30 2022 financial results.

Wachsende Gewinnspanne: MPH's current net profit margins (2.1%) are lower than last year (2.8%).

Analyse von freiem Cashflow und Gewinn

Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: MPH's earnings have declined by 21.5% per year over the past 5 years.

Beschleunigtes Wachstum: MPH's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Erträge im Vergleich zur Industrie: MPH had negative earnings growth (-18.7%) over the past year, making it difficult to compare to the Personal Products industry average (8.9%).

Eigenkapitalrendite

Hohe Eigenkapitalrendite: MPH's Return on Equity (2%) is considered low.

Kapitalrendite

Rendite auf das eingesetzte Kapital

Entdecken Sie starke Unternehmen, die in der Vergangenheit erfolgreich waren

7D

1Y

7D

1Y

7D

1Y